Kopran

{
  "main_header": {
    "sid": 568367,
    "name": "Kopran",
    "stock_name": "Kopran",
    "full_name": "Kopran Ltd",
    "name_url": "stocks-analysis/kopran",
    "exchange": 1,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "115.00",
    "chg": -3.22,
    "chgp": "-2.72%",
    "dir": -1,
    "prev_price": "118.22",
    "mcapval": "555.28 Cr",
    "mcap": "Micro Cap",
    "scripcode": 524280,
    "symbol": "KOPRAN",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE082A01010",
    "curr_date": "Mar 23",
    "curr_time": "",
    "bse_nse_vol": "3.22 lacs",
    "exc_status": "Active",
    "traded_date": "Mar 23, 2026",
    "traded_date_str": "2026 03 23",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/kopran-568367-1&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Kopran Ltd Falls to 52-Week Low of Rs 111 as Sell-Off Deepens",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/kopran-ltd-stock-falls-to-52-week-low-of-rs111-amid-continued-downtrend-3907978",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/KopranLtd_priceRelatedfactors_3907978.png",
        "date": "2026-03-23 13:10:18",
        "description": "For the fifth consecutive session, Kopran Ltd closed lower, hitting a fresh 52-week low of Rs 111 on 23 Mar 2026. This decline comes amid a broader market sell-off, but the stock’s underperformance is notably sharper than its sector peers and the benchmark indices."
      },
      {
        "title": "Kopran Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/kopran-ltd-is-rated-strong-sell-3904828",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/KopranLtd_mojoScore_3904828.png",
        "date": "2026-03-21 10:10:36",
        "description": "Kopran Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 25 February 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 21 March 2026, providing investors with an up-to-date perspective on the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Kopran Ltd Stock Hits 52-Week Low Amid Continued Downtrend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/kopran-ltd-stock-hits-52-week-low-amid-continued-downtrend-3893561",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/KopranLtd_priceRelatedfactors_3893561.png",
        "date": "2026-03-16 10:52:07",
        "description": "Kopran Ltd’s shares declined to a fresh 52-week low of Rs.112.1 today, marking a significant milestone in the stock’s ongoing downward trajectory. The pharmaceutical company’s stock has underperformed both its sector and the broader market, reflecting a series of financial setbacks and subdued performance metrics over recent quarters."
      },
      {
        "title": "Kopran Ltd Stock Falls to 52-Week Low of Rs.115.65 Amid Continued Downtrend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/kopran-ltd-stock-falls-to-52-week-low-of-rs11565-amid-continued-downtrend-3890119",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/KopranLtd_priceRelatedfactors_3890119.png",
        "date": "2026-03-13 19:28:48",
        "description": "Kopran Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, recorded a fresh 52-week low of Rs.115.65 today, marking a significant decline amid a sustained downward trend. The stock has underperformed its sector and broader market indices, reflecting ongoing pressures on its financial performance and valuation metrics."
      },
      {
        "title": "Kopran Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/kopran-ltd-is-rated-strong-sell-3882314",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/KopranLtd_mojoScore_3882314.png",
        "date": "2026-03-10 10:10:50",
        "description": "Kopran Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 25 February 2026. However, the analysis and financial metrics discussed below reflect the stock’s current position as of 10 March 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance."
      },
      {
        "title": "Kopran Ltd Stock Falls to 52-Week Low Amid Continued Underperformance",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/kopran-ltd-stock-falls-to-52-week-low-amid-continued-underperformance-3880001",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/KopranLtd_priceRelatedfactors_3880001.png",
        "date": "2026-03-09 12:31:35",
        "description": "Kopran Ltd’s shares declined to a fresh 52-week low of Rs.115.75 on 9 Mar 2026, marking a significant milestone in the stock’s ongoing downward trajectory. The pharmaceutical company’s stock has underperformed both its sector and the broader market, reflecting persistent challenges in financial performance and market sentiment."
      },
      {
        "title": "Kopran Ltd Technical Momentum Shifts Amid Bearish Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/kopran-ltd-technical-momentum-shifts-amid-bearish-signals-3868177",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/KopranLtd_technicaldot_3868177.png",
        "date": "2026-03-04 08:03:17",
        "description": "Kopran Ltd, a key player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, with recent indicators signalling a transition from mildly bearish to a more pronounced bearish trend. Despite some mildly bullish signals on weekly MACD and KST, the overall technical landscape remains challenging, reflecting in the company’s downgraded Mojo Grade to Strong Sell and a significant price decline in early March 2026."
      },
      {
        "title": "Kopran Ltd Gains 1.19% Despite Strong Sell Downgrade: 3 Key Factors Driving the Week",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/kopran-ltd-gains-119-despite-strong-sell-downgrade-3-key-factors-driving-the-week-3862579",
        "imagepath": "",
        "date": "2026-02-28 16:02:35",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>Feb 23:</strong> Stock opens at Rs.128.65, down 1.00% amid Sensex gains</p>\n                    <p><strong>Feb 24:</strong> Price unchanged at Rs.128.65 despite Sensex decline</p>\n                    <p><strong>Feb 25:</strong> Price rises 0.86% to Rs.129.75, technical momentum shifts</p>\n                    <p><strong>Feb 26:</strong> Mojo Grade downgraded to Strong Sell; price jumps 2.62% to Rs.133.15</p>\n                    <p><strong>Feb 27:</strong> Mixed technical signals as price retreats 1.24% to Rs.131.50</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-va..."
      },
      {
        "title": "Kopran Ltd Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/kopran-ltd-technical-momentum-shifts-amid-mixed-market-signals-3859518",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/KopranLtd_technicaldot_3859518.png",
        "date": "2026-02-27 08:01:27",
        "description": "Kopran Ltd, a Pharmaceuticals & Biotechnology micro-cap, has exhibited a nuanced shift in technical momentum as recent data reveals a transition from a strongly bearish stance to a mildly bearish trend. Despite a modest 2.5% gain in the latest session, the company’s technical indicators present a mixed picture, underscoring the challenges faced in reversing longer-term downtrends amid sectoral headwinds and broader market dynamics."
      }
    ],
    "total": 285,
    "sid": "568367",
    "stock_news_url": "https://www.marketsmojo.com/news/kopran-568367"
  },
  "announcements": [
    {
      "details": "Kopran Limited has informed the Exchange regarding Disclosure of Related Party Transactions pursuant to Regulation 23(9) of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 for the half year ended September 30, 2019",
      "source": "NSE",
      "caption": "Kopran Limited - Other General Purpose",
      "datetime": "08-Nov-2019"
    },
    {
      "details": " <table><tr><td>Kopran Limited has informed the Exchange regarding Board meeting held on September 11, 2019. </td></tr></table>",
      "source": "NSE",
      "caption": "Outcome of Board Meeting",
      "datetime": "11-Sep-2019"
    },
    {
      "details": " <table><tr><td>Kopran Limited has submitted to the Exchange, the financial results for the period ended June 30, 2019. </td></tr></table>",
      "source": "NSE",
      "caption": "Financial Result Updates",
      "datetime": "08-Aug-2019"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Kopran Ltd has declared <strong>30%</strong> dividend, ex-date: 04 Sep 25",
          "dt": "2025-09-04",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Kopran Ltd Falls to 52-Week Low of Rs 111 as Sell-Off Deepens

2026-03-23 13:10:18

For the fifth consecutive session, Kopran Ltd closed lower, hitting a fresh 52-week low of Rs 111 on 23 Mar 2026. This decline comes amid a broader market sell-off, but the stock’s underperformance is notably sharper than its sector peers and the benchmark indices.

Read full news article

Kopran Ltd is Rated Strong Sell

2026-03-21 10:10:36

Kopran Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 25 February 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 21 March 2026, providing investors with an up-to-date perspective on the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Kopran Ltd Stock Hits 52-Week Low Amid Continued Downtrend

2026-03-16 10:52:07

Kopran Ltd’s shares declined to a fresh 52-week low of Rs.112.1 today, marking a significant milestone in the stock’s ongoing downward trajectory. The pharmaceutical company’s stock has underperformed both its sector and the broader market, reflecting a series of financial setbacks and subdued performance metrics over recent quarters.

Read full news article

Kopran Ltd Stock Falls to 52-Week Low of Rs.115.65 Amid Continued Downtrend

2026-03-13 19:28:48

Kopran Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, recorded a fresh 52-week low of Rs.115.65 today, marking a significant decline amid a sustained downward trend. The stock has underperformed its sector and broader market indices, reflecting ongoing pressures on its financial performance and valuation metrics.

Read full news article

Kopran Ltd is Rated Strong Sell

2026-03-10 10:10:50

Kopran Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 25 February 2026. However, the analysis and financial metrics discussed below reflect the stock’s current position as of 10 March 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.

Read full news article

Kopran Ltd Stock Falls to 52-Week Low Amid Continued Underperformance

2026-03-09 12:31:35

Kopran Ltd’s shares declined to a fresh 52-week low of Rs.115.75 on 9 Mar 2026, marking a significant milestone in the stock’s ongoing downward trajectory. The pharmaceutical company’s stock has underperformed both its sector and the broader market, reflecting persistent challenges in financial performance and market sentiment.

Read full news article

Kopran Ltd Technical Momentum Shifts Amid Bearish Signals

2026-03-04 08:03:17

Kopran Ltd, a key player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, with recent indicators signalling a transition from mildly bearish to a more pronounced bearish trend. Despite some mildly bullish signals on weekly MACD and KST, the overall technical landscape remains challenging, reflecting in the company’s downgraded Mojo Grade to Strong Sell and a significant price decline in early March 2026.

Read full news article

Kopran Ltd Gains 1.19% Despite Strong Sell Downgrade: 3 Key Factors Driving the Week

2026-02-28 16:02:35

Key Events This Week

Feb 23: Stock opens at Rs.128.65, down 1.00% amid Sensex gains

Feb 24: Price unchanged at Rs.128.65 despite Sensex decline

Feb 25: Price rises 0.86% to Rs.129.75, technical momentum shifts

Feb 26: Mojo Grade downgraded to Strong Sell; price jumps 2.62% to Rs.133.15

Feb 27: Mixed technical signals as price retreats 1.24% to Rs.131.50

Week Open

Read full news article

Kopran Ltd Technical Momentum Shifts Amid Mixed Market Signals

2026-02-27 08:01:27

Kopran Ltd, a Pharmaceuticals & Biotechnology micro-cap, has exhibited a nuanced shift in technical momentum as recent data reveals a transition from a strongly bearish stance to a mildly bearish trend. Despite a modest 2.5% gain in the latest session, the company’s technical indicators present a mixed picture, underscoring the challenges faced in reversing longer-term downtrends amid sectoral headwinds and broader market dynamics.

Read full news article

View All News